Cargando…
Reappraisal of the clinical use of leflunomide in rheumatoid arthritis and psoriatic arthritis
Leflunomide is a disease-modifying antirheumatic drug (DMARD) that has been in routine clinical use for the treatment of rheumatoid arthritis (RA) and psoriatic arthritis for a decade. In RA, clinical trials of up to two years’ duration showed that leflunomide monotherapy was equivalent to methotrex...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5074775/ https://www.ncbi.nlm.nih.gov/pubmed/27789998 http://dx.doi.org/10.2147/OARRR.S9448 |